BusinessInspireMD’s CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017By Nasdaq OMXDec 7, 2017, 5:23 PM UTC
BusinessUltragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) DeficiencyBy Nasdaq OMXNov 16, 2017, 1:30 PM UTC
BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
BusinessETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.By Nasdaq OMXNov 21, 2016, 1:15 PM UTC
BusinessEarth Science Tech Announces Strategic Alliance with RRNP Healthcare and Dysfunctional Veterans of New Hampshire to conduct its First 30-Day PTSD Clinical Study with Veterans using ETST High Grade Hemp CBD (Cannabidiol) OilBy Nasdaq OMXMar 28, 2016, 12:00 PM UTC
BusinessMatinas BioPharma Commences Patient Enrollment in NIH-Sponsored Phase 2a Study With MAT2203 - Oral Encochleated Amphotericin BBy Nasdaq OMXFeb 8, 2016, 12:05 PM UTC
